As of Apr 26, 2024, the Edwards Lifesciences stock's PE ratio is 37.42. This takes into account the latest EPS of $2.31 and stock price of $86.43. The PE ratio has grown by 8% from its last 4 quarters average of 34.6.
The PE ratio of Edwards Lifesciences has averaged 40.76 over the last ten years. The current P/E ratio of 37.42 is 8% lower than the historical average. Looking back at the last ten years, EW's PE ratio peaked in the Dec 2020 quarter at 69.11, when the price was $91.23 and the EPS was $1.32. The lowest point was in the Jun 2014 quarter, when it reached 12.02 with a price of $14.31 and an EPS of $1.19.
Maximum annual increase: 104.49% in 2015
Maximum annual decrease: -43.58% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 33.01 | 8.84% |
| 2022 | 30.33 | -43.58% |
| 2021 | 53.76 | -22.21% |
| 2020 | 69.11 | 49.3% |
| 2019 | 46.29 | 4.26% |
| 2018 | 44.4 | 8.72% |
| 2017 | 40.84 | 16.39% |
| 2016 | 35.09 | 2.63% |
| 2015 | 34.19 | 104.49% |
| 2014 | 16.72 | -11.53% |
Currently, EW's PE ratio is lower than its 3, 5 and 10-year averages.
EW's PE ratio stands lower than its peer stocks BSX and MMSI, but it is higher than MDT's. Edwards Lifesciences is currently trading at a lower PE ratio (37.42) than its peers average of 46.55.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MDT Medtronic plc | 25.31 | $105.88B |
| EW Edwards Lifesciences Corp | 37.42 | $51.94B |
| MMSI Merit Medical Systems Inc | 44.99 | $4.27B |
| LMAT Lemaitre Vascular Inc | 48.13 | $1.46B |
| BSX Boston Scientific Corp | 67.75 | $107.35B |
| ICUI Icu Medical Inc | N/A | $2.29B |
The price to earnings ratio for EW stock as of Apr 26, 2024, stands at 37.42.
The 3-year average price to earnings ratio for EW stock is 39.81.
The 5-year average price to earnings ratio for EW stock is 46.51.
The highest quarterly PE ratio in the last ten years has been 69.11 and it was in the Dec 2020 quarter.
EW's price to earnings ratio is currently 8% below its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Apr 26, 2024), Edwards Lifesciences's share price is $86.43. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $2.31. Therefore, Edwards Lifesciences's PE ratio for today is 37.42. PE RATIO(37.42) = STOCK PRICE($86.43) / TTM EPS($2.31)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.